On Thursday, Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s shares declined -2.97% to $3.59.
Idera Pharmaceuticals Inc (IDRA) declared that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for IMO-8400, an antagonist of the endosomal Toll-like receptors (TLRs) 7, 8 and 9, for the treatment of diffuse large B-cell lymphoma (DLBCL).
Idera is presently conducting a clinical trial of IMO-8400 in patients with relapsed or refractory DLBCL harboring MYD88 L265P oncogenic mutation (ClinicalTrials.gov identifier NCT02252146). Preclinical studies have shown that in B-cell lymphomas characterized by the MYD88 L265P oncogenic mutation, counting DLBCL, TLR signaling is over-activated, thereby enabling tumor cell survival and proliferation. As a TLR antagonist, IMO-8400 inhibits TLR signaling.
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States.
Applied Materials, Inc. (NASDAQ:AMAT)’s shares dropped -2.97% to $21.88.
Applied Materials, Inc. (NASDAQ:AMAT) disclosed that its Board of Directors has approved a quarterly cash dividend of $0.10 per share payable on the company`s common stock. The dividend is payable on June 11, 2015 to stockholders of record as of May 21, 2015.
If Applied Materials` projected business combination with Tokyo Electron Limited closes before May 21, 2015, the record date will be a date before the closing date. In such event, the dividend will be pro-rated, with stockholders receiving $0.001087 per share for each day starting February 19, 2015, the day after the record date for the previous quarterly dividend, and ending on the record date. The pro-rated dividend, which ensures that stockholders continue to receive dividends at the current rate, will be payable within 60 days of the record date.
Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, flat panel display, solar photovoltaic (PV), and related industries worldwide. The company’s Silicon Systems Group segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits.
At the end of Thursday’s trade, Compania de Minas Buenaventura SAA (ADR) (NYSE:BVN)‘s shares dipped -2.95% to $10.53.
ALLIANCE MINING CORP, reveal that on April 10, 2015 it reached two memorandum of understanding (each, a “MOU”) with Compania de Minas Buenaventura, a Peruvian mining company, regarding the purchase of a 100% interest in properties comprising of past producing mines located in South Eastern Peru: the Shila-Paula Mine property and the Poracota Mine property.
Further to a company news release dated January 5 2015, The Company is ongoing to finalize its due diligence and has placed a USD$200,000 deposit and signed the MOU’s associated with these projects in-order to work towards concluding a definitive contract within the next 45 days for April 10 2015.
Compañía de Minas Buenaventura S.A.A., a precious metals company, is engaged in the exploration, mining, and processing of gold and silver. It also explores for other metals, counting lead, zinc, and copper.
Molycorp Inc(NYSE:MCP), ended its Thursday’s trading session with -2.93% loss, and closed at $14.24.
Siemens AG has selected Molycorp Inc (MCP) to supply rare earth materials over the next 10 years from its Mountain Pass, California facility for incorporation into Siemens’ high-efficiency, direct drive wind turbine generators. Molycorp will supply rare earth materials to Shin-Etsu Chemical Co., Ltd., which will produce the rare earth magnets Siemens intends to utilize in its wind turbines.
Siemens officials noted that key factors in choosing Molycorp were Molycorp’s ability to provide greater global diversification and reliability to its supply chain, in addition to the environmental and process innovations Molycorp has built into its Mountain Pass rare earth facility. Among those innovations are the facility’s ability to recycle water, regenerate the chemical reagents needed in rare earth production, generate power from a high-efficiency natural gas cogeneration power plant, and dispose of mine tailings through an innovative paste tailings system.
Molycorp, Inc. produces and sells rare earths and rare metal materials in the United States and internationally. The company’s Resources segment extracts rare earth minerals, counting light rare earth concentrates; rare earth oxides (REO), such as lanthanum, cerium, and neodymium-praseodymium; heavy rare earth concentrates, which comprise samarium, europium, gadolinium, terbium, dysprosium, and others; and SorbX and PhosFIX, a line of rare earth-based water treatment products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
